WASHINGTON, DC — The American Institute for Medical and Biological Engineering (AIMBE) recognizes President Obama’s FY 2013 budget and how its priorities affect the bioengineering community.
By Rebecca Adams, CQ Healthbeat Associate Editor Congress must renew a law to allow the Food and Drug Administration to continue approving life-saving drugs and devices. But this renewal has already attracted a myriad of amendments unrelated to the user fees that lawmakers are being asked to approve. The FDA relies on user fees from [...]
WASHINGTON, D.C. – The American Institute for Medical and Biological Engineering (AIMBE) is proud to announce a new Network of Experts Agreement with the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA).